Janux Therapeutics, Inc.

JANX · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$48,389$52,446$73,743$430,605
Short-Term Investments$940,604$943,565$940,403$594,568
Receivables$6,315$5,691$5,585$5,381
Inventory$0$0$0$0
Other Curr. Assets$2,778$3,851$3,608$3,112
Total Curr. Assets$998,086$1,005,553$1,023,339$1,033,666
Property Plant & Equip (Net)$23,237$23,150$23,825$24,150
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$816$816$0$0
Tax Assets$0$0$0$0
Other NC Assets$2,627$2,693$3,608$3,700
Total NC Assets$26,680$26,659$27,433$27,850
Other Assets$0$0$0$0
Total Assets$1,024,766$1,032,212$1,050,772$1,061,516
Liabilities
Payables$3,395$3,477$2,351$4,026
Short-Term Debt$2,280$1,873$1,811$1,749
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$22,156$16,029$13,340$11,684
Total Curr. Liab.$27,831$21,379$17,502$17,459
LT Debt$20,380$20,317$20,801$21,276
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$20,380$20,317$20,801$21,276
Other Liabilities$0$0$0$0
Cap. Leases$20,380$22,190$22,612$23,025
Total Liabilities$48,211$41,696$38,303$38,735
Equity
Pref Stock$0$0$0$0
Common Stock$60$59$59$59
Retained Earnings-$319,436-$295,123-$261,265-$237,757
AOCI$4,562$3,747$3,756$2,163
Other Equity$1,291,369$1,281,833$1,269,919$1,258,316
Total Equity$976,555$990,516$1,012,469$1,022,781
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$1,024,766$1,032,212$1,050,772$1,061,516
Net Debt-$25,729-$30,256-$51,131-$407,580